News

Taiwan News21h
U.S. Digital Therapeutics Market to Reach USD 5.08 Billion by 2027, Growing at a CAGR of 19.2% from 2019
The U.S. digital therapeutics market size was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period. Increase in adoption of ...
Small Molecule Innovator API CDMO Market to Hit $47.14 Billion by 2030 at 6.38% CAGR, Driven by Outsourcing Trends and Drug Innovation
CDMOs Expand Capabilities Amid Surge in Clinical Trials and Demand for Orphan Drugs and Novel TherapiesDublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, ...
Selective Laser Sintering Equipment Market to Hit USD 5007.08 million by 2032, at a CAGR of 23.33% | SNS Insider
Equipment Market is growing with demand for rapid prototyping and complex part manufacturing, driven by advancements in 3D ...
Healthcare Dive4h
Growing market volatility spooks hospital analysts
Should health systems see their investment income decline, cash on hand could fall nearly 7% from the first half of 2024, ...
TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...
Taiwan News21h
Patient-Centric Healthcare App Market to Reach USD 64.33 Billion by 2027, Growing at a CAGR of 37.2% from 2020
The patient centric healthcare app accounted for $4,730 million in 2019, and is expected to reach $64,331 million by 2027, registering a CAGR of 37.2% from 2020 to 2027. The global patient centric ...
Becker's Hospital Review4h
Hospitals face competitive strategy reboot amid price transparency
Donald Trump issued an executive order Feb. 25 that would heighten price transparency enforcement for hospitals and health plans. If the order is enforced, big changes may be ahead for healthcare ...
Le Lézard21h
FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight
DelveInsight's "FYARRO Market Size, Forecast, and Market Insight Report" highlights the details around FYARRO, an mTOR inhibitor. The report provides product descriptions, patent details, and ...
Huntington's Disease Treatment Market To Hit $2.03 Billion By 2033, Driven By Cutting-Edge Therapies
Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbe ...
Becker's Hospital Review6h
Healthcare advocacy takes on newfound prominence
Leaders in healthcare sit in a unique space, with a keen understanding of the complex funding mechanisms that support healthcare delivery and education. At a time of heightened economic and political ...
DelveInsight Business Research, LLP: TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension inadequately controlled by existing treatments. TRYVIO ...
DelveInsight Business Research, LLP: FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight
FYARRO holds strong market potential, particularly in treating rare and aggressive cancers like PEComa, where treatment options are limited. As the first FDA-approved therapy for advanced PEComa ...